Innovating Works

AMNIOTICS

Desconocido
HyperTargIPS-NK: Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor... AMNIOTICS AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 The HyperTargIPS-NK project aims to combine novel technologies from three research laboratories and a stem cell company to develop a revolut...
2023-01-19 - 2026-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.